VE

Vishnu Enchappilly Rajan

Active Director Director DIN 09505455
DIN 09505455 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vishnu Enchappilly Rajan

Data last updated:

Vishnu Enchappilly Rajan is a Director at Healeodor Medcorp Private Limited (since 2022). The company operates in Chemicals.

DIN 09505455
Primary Designation Director
Industry Chemicals
First Appointment 14 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healeodor Medcorp Private Limited U24230KL2022PTC074017
Director14 Feb 20222022Active

Board colleagues of Vishnu Enchappilly Rajan

Directorship timeline

Open interactive timeline →
Healeodor Medcorp Private Limited
Premium access

Shareholding and investment profile for Vishnu Enchappilly Rajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishnu Enchappilly Rajan

Vishnu Enchappilly Rajan currently holds 1 directorship: Healeodor Medcorp Private Limited (Director, since 14 Feb 2022).

Vishnu Enchappilly Rajan was first appointed on 14 Feb 2022 as Director at Healeodor Medcorp Private Limited.

The current boards of Vishnu Enchappilly Rajan's companies include Jayakaladevi Ambujakshi Lakshmanan (Healeodor Medcorp Private Limited), Nikhil Manoharan Sushama (Healeodor Medcorp Private Limited), Nimy Thomas (Healeodor Medcorp Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available